OnabotulinumtoxinA for Treatment of Moderate-To-Severe Horizontal Lines and Glabellar Lines From the Subject's Perspective: Patient-Reported Satisfaction and Impact Outcomes From a Phase 3 Double-Blind Study

SKIN The Journal of Cutaneous Medicine
doi 10.25251/skin.1.supp.81
Full Text
Abstract

Available in full text

Date
Authors
Publisher

National Society for Cutaneous Medicine


Related search